Assign modules on offcanvas module position to make them visible in the sidebar.

The muscular dystrophies (MD) are a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement.

In the course of MD treatment with stem cells, pools of genetically healthy cells are created in the patient’s body. These cell pools are capable of producing dystrophin, which can then penetrate affected cells. Moreover, during the course of determination, differentiation, and morphogenesis, transplanted stem cells produce pools of specialized cells that the patient’s body needs, such as muscular, nervous, endothelial, and so on. Stem cell treatment offers two main kinds of result:

• production of healthy muscle fibers: Stem cells without the genetic defect that causes MD can be delivered to a patient’s muscles, where they generate working muscle fibers to replace damaged ones.

• reduced inflammation: In muscular dystrophy, damaged muscles become quite inflamed and this inflammation speeds up muscle degeneration. Stem cells release chemicals that reduce inflammation, slowing the progress of the disease.

MD treatment takes place at different stages of the disease, at different ages, at different levels of muscle atrophy, and at different levels of patient capacity for independent motion—bedridden, in a wheelchair, or able to walk independently.

stem cells facilitate the synthesis of dystrophin, the deficiency of which causes the disease. Our treatment helps lead to:

• inhibition of MD progress;

• prevention of muscle fiber destruction and the preservation of muscle power and bulk;

• prevention of complications such as respiratory and heart failure;

• CPK, LDH, ALT and ACT declines indicative of a reduction in muscle destruction;

• preservation of relative activity and capacity for independent living;

• boosted immune system;

• better functioning of internal organs and systems;

• overall improvement in quality of life.